Physician profile
Thiru Rajagopal
NPI 1124132246
$4,691.96
in general payments reported to CMS, 2019-2025
13 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $142 · 2022: $371 · 2023: $457 · 2024: $1,787 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447 · Travel and Lodging: $1,169 · Entertainment: $16.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.56 |
| Travel and Lodging | $1,168.54 |
| Entertainment | $16.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $3,429.49 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $333.18 | 2019-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $296.69 | 2023-2024 | Phasix Mesh |
| Genentech USA, INC. | $148.84 | 2019 | |
| Hologic INC | $134.39 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.54 | 2019 | |
| Stryker Corporation | $70.19 | 2023 | 1688 |
| Integra Lifesciences Corporation | $69.30 | 2022 | |
| Polynovo North America LLC | $43.34 | 2022 | |
| Ethicon US, LLC | $37.20 | 2019 | |
| Leica Microsystems INC. | $20.39 | 2020 | |
| Hologic Sales and Service, LLC | $19.11 | 2025 | Magtrace |
| Kub Technologies INC. | $16.30 | 2023 | Mozart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thiru Rajagopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.